The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PDE2 INHIBITORS
申请人:Janssen Pharmaceutica NV
公开号:EP3535267B1
公开(公告)日:2020-12-30
CARBOXYESTERASE POLYPEPTIDES FOR AMIDE COUPLING
申请人:Codexis, Inc.
公开号:US20210238565A1
公开(公告)日:2021-08-05
The present invention provides engineered carboxyesterase enzymes having improved properties as compared to a naturally occurring wild-type carboxyesterase enzymes, as well as polynucleotides encoding the engineered carboxyesterase enzymes, host cells capable of expressing the engineered carboxyesterase enzymes, and methods of using the engineered carboxyesterase enzymes in amidation reactions.